Humanity & Health Medical Group Limited

ACTIVE

People's Republic of Chinawww.hnhmgl.com/enPrivateEstablished: 2009-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2009

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

33.3%

Phase 4

22.2%

Trial Status Distribution

Completed

33.3%

Recruiting

33.3%

Terminated

11.1%

Withdrawn

22.2%

Clinical Trials

Trials sponsored by this organization (9)

Liver Injury After COVID-19 Vaccination

Completed

observational

Sep 2022379 participants

A Study to Evaluate Vaccines Against COVID-19 in the Real World

Withdrawn

observational

Aug 2022

Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors

Terminated

observational

Jul 202217 participants

Antibody Response to COVID-19 Vaccines in Liver Disease Patients

Phase 4

Completed

interventional

May 2021232 participants

Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC

Phase 2

Recruiting

interventional

May 201930 participants

Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection

Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)

Phase 4

Recruiting

interventional

Dec 20182,000 participants

The Overall Survival of Patients With Unresectable HCC in Real-life

Recruiting

observational

Jul 20185,000 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations